Literature DB >> 21352950

Reduced immunogenicity of pancreatic progenitor cells derived from first-trimester human fetal pancreas.

Man Ting Ma1, Kwan Keung Leung, Kam Sze Tsang, Po Sing Leung.   

Abstract

The relatively low immunogenic and tumorigenic nature of fetal stem cells makes them attractive candidates for transplantation. Pancreatic progenitor cells (PPCs) derived from human fetal pancreas that are amenable to growth and differentiation into transplantable insulin-producing islet-like cell clusters (ICCs) have been reported recently; however, the immunological nature of these cells has yet to be characterized. We thus investigated and compared the immunogenicity of pancreatic progenitor cells and islet-like cell clusters from first- and second-trimester human fetal pancreas. Polymerase chain reaction demonstrated that pancreatic progenitor cells and islet-like cell clusters express immune-related genes of major histocompatibility complex, MHC-I and MHC-II, complement component 3 (C3), chemokine ligand (CCL19), and tumor necrosis factor super family (TNFSF10), but no expression of the co-stimulatory genes, CD80 and CD86. Interestingly, pancreatic progenitor cells showed a differential expression of MHC-I and MHC-II with advancing gestational age with a greater expression in pancreatic progenitor cells from the second trimester. Pre-incubation of the second-trimester cells with interferon-γ (IFN-γ) increased MHC molecule expression. Functional alloreactivity of pancreatic progenitor cells was investigated via mixed lymphocyte reactions (MLRs). Relative to first-trimester pancreatic progenitor cells, second-trimester pancreatic progenitor cells induced a greater extent of proliferation of peripheral blood mononuclear cells (PBMCs) and resulted in more IFN-γ production in phytohaemagllutinin-stimulated peripheral blood mononuclear cells following co-culture. Results of the study indicated that first-trimester pancreatic progenitor cells and islet-like cell clusters have a distinctively lower immunogenicity relative to second-trimester pancreatic progenitor cells, even after a pro-inflammatory cytokine challenge.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352950     DOI: 10.1016/j.biocel.2011.02.006

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  4 in total

1.  Human fetal liver stromal cell co-culture enhances the differentiation of pancreatic progenitor cells into islet-like cell clusters.

Authors:  Juan Liang; Ka Yan Ng; Qianni Cheng; Yin Xia; Chi Chiu Wang; Po Sing Leung
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

2.  Xeno-free protocol for GMP-compliant manufacturing of human fetal pancreas-derived mesenchymal stem cells.

Authors:  Zahra Jabbarpour; Sajjad Aghayan; Babak Arjmand; Khadijeh Fallahzadeh; Sepideh Alavi-Moghadam; Bagher Larijani; Hamid Reza Aghayan
Journal:  Stem Cell Res Ther       Date:  2022-06-21       Impact factor: 8.079

3.  Transplantation of human fetal pancreatic progenitor cells ameliorates renal injury in streptozotocin-induced diabetic nephropathy.

Authors:  Yongwei Jiang; Wenjian Zhang; Shiqing Xu; Hua Lin; Weiguo Sui; Honglin Liu; Liang Peng; Qing Fang; Li Chen; Jinning Lou
Journal:  J Transl Med       Date:  2017-06-27       Impact factor: 5.531

4.  Human Fetal Bone Marrow-Derived Mesenchymal Stem Cells Promote the Proliferation and Differentiation of Pancreatic Progenitor Cells and the Engraftment Function of Islet-Like Cell Clusters.

Authors:  Xing Yu Li; Shang Ying Wu; Po Sing Leung
Journal:  Int J Mol Sci       Date:  2019-08-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.